Search Results - Horst Zincke
- Showing 1 - 19 results of 19
-
1
Pathologic staging of renal cell carcinoma by Matthew T. Gettman, Michael L. Blute, BRUCE SPOTTS, Sandra C. Bryant, Horst Zincke
Published 2001Artigo -
2
-
3
Carcinoma <i>in Situ</i> of the Bladder by David C. Utz, George M. Farrow, Charles C. Rife, Joseph W. Segura, Horst Zincke
Published 1980Artigo -
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
Workgroup 2: Staging and reporting of prostate cancer--Sampling of the radical prostatectomy specimen by Wael Sakr, Thomas M. Wheeler, Michael L. Blute, M Bodó, Rocio Calle-Rodrigue, Donald E. Henson, F. K. Mostofi, Jennifer Seiffert, Kirk J. Wojno, Horst Zincke
Published 1996Artigo -
13
Stage D1 prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment. Evidence for favorable survival in patients with DNA diploid tumors by Horst Zincke, Erik J. Bergstralh, Jeffrey J. Larson-Keller, George M. Farrow, Robert P. Myers, Michael M. Lieber, David M. Barrett, Charles C. Rife, Nick J. Gonchoroff
Published 1992Artigo -
14
Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness by Shomik Sengupta, Christine M. Lohse, Bradley C. Leibovich, Igor Frank, R. Houston Thompson, W. Scott Webster, Horst Zincke, Michael L. Blute, John C. Cheville, Eugene D. Kwon
Published 2005Artigo -
15
-
16
Costimulatory molecule B7‐H1 in primary and metastatic clear cell renal cell carcinoma by R. Houston Thompson, Michael D. Gillett, John C. Cheville, Christine M. Lohse, Haidong Dong, W. Scott Webster, Lieping Chen, Horst Zincke, Michael L. Blute, Bradley C. Leibovich, Eugene D. Kwon
Published 2005Artigo -
17
Tumor B7-H1 Is Associated with Poor Prognosis in Renal Cell Carcinoma Patients with Long-term Follow-up by R. Houston Thompson, Susan M. Kuntz, Bradley C. Leibovich, Haidong Dong, Christine M. Lohse, W. Scott Webster, Shomik Sengupta, Igor Frank, Alexander S. Parker, Horst Zincke, Michael L. Blute, Thomas J. Sebo, John C. Cheville, Eugene D. Kwon
Published 2006Artigo -
18
618: Costimulatory B7-H1 In Renal Cell Carcinoma Patients: Indicator of Tumor Aggressiveness and Potential Therapeutic Target by R. Houston Thompson, Michael D. Gillett, John C. Cheville, Christine M. Lohse, Haidong Dong, W. Scott Webster, Kent G. Krejci, John R. Lobo, Shomik Sengupta, Lieping Chen, Horst Zincke, Michael L. Blute, Scott E. Strome, Bradley C. Leibovich, Eugene D. Kwon
Published 2005Artigo -
19
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target by R. Houston Thompson, Michael D. Gillett, John C. Cheville, Christine M. Lohse, Haidong Dong, W. Scott Webster, Kent G. Krejci, John R. Lobo, Shomik Sengupta, Lieping Chen, Horst Zincke, Michael L. Blute, Scott E. Strome, Bradley C. Leibovich, Eugene D. Kwon
Published 2004Artigo
Search Tools:
Related Subjects
Medicine
Internal medicine
Cancer
Carcinoma
Biology
Oncology
Pathology
Paleontology
Stage (stratigraphy)
Urology
Prostate cancer
Confidence interval
Renal cell carcinoma
Kidney
Surgery
Clear cell renal cell carcinoma
Metastasis
Nephrectomy
Prostate
Bladder cancer
Clear cell
Cystectomy
Lymph node
Prostatectomy
Tumor progression
Cancer research
Carcinoma in situ
Chromophobe cell
Cohort
Cohort study